articleNature MedicineSep 21, 2003Closed access

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

CUCatherine UyttenhoveLPLuc PilotteITIvan ThéateVSVincent StroobantDCDidier Colau

Ludwig Cancer Research · UCLouvain

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,287
total citations
FWCI
25.26
Percentile
100%
References
40
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Indoleamine 2,3-dioxygenase
  • Immune system
  • Tryptophan
  • Cancer research
  • Economic shortage
  • Immune tolerance
  • Immunology
  • Tryptophan Metabolism
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.